First Manhattan’s Takeda Pharmaceutical TAK Stock Holding History

First Manhattan’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-94	Closed	-$1.3K	–	1246
2024 Q1	$1.3K	Hold	94	–	–	﹤0.01%	1323
2023 Q4	$1.34K	Sell	94 -105	-53%	-$1.49K	﹤0.01%	1313
2023 Q3	$3.08K	Buy	199 +105	+112%	+$1.63K	﹤0.01%	1281
2023 Q2	$1.48K	Hold	94	–	–	﹤0.01%	1317
2023 Q1	$1.55K	Hold	94	–	–	﹤0.01%	1397
2022 Q4	$1.47K	Hold	94	–	–	﹤0.01%	1550
2022 Q3	$1K	Hold	94	–	–	﹤0.01%	1487
2022 Q2	$1K	Hold	94	–	–	﹤0.01%	1514
2022 Q1	$1K	Hold	94	–	–	﹤0.01%	1557
2021 Q4	$1K	Hold	94	–	–	﹤0.01%	1542
2021 Q3	$1K	Buy	+94	New	+$1.58K	﹤0.01%	1562

Other funds holding TAK

GAM

Groupama Asset Management Paris, France $7.93B AUM 57.28% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

First Manhattan's TAK Position: Q2 2024 in Review

First Manhattan sold out of Takeda Pharmaceutical (TAK) in Q2 2024, closing a stake of 94 shares — an estimated $1.3K sold.

First Manhattan first reported a position in TAK in Q3 2021 and held it in 11 quarters. The position peaked at $3.08K in Q3 2023. 284 funds tracked by Wall St. Rank hold TAK as of Q2 2024.

First Manhattan reported no remaining Takeda Pharmaceutical position as of Q2 2024 after selling out during the quarter.
First Manhattan sold 94 Takeda Pharmaceutical shares in Q2 2024, an estimated $1.3K.
First Manhattan first reported a position in Takeda Pharmaceutical in Q3 2021 and held it in 11 quarters.
First Manhattan's Takeda Pharmaceutical position peaked at $3.08K in Q3 2023.
284 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2024.

Based on First Manhattan's 13F filing for Q2 2024, filed 14 Aug 2024.